₹38.82
+0.16 (+0.41%)
As of 23 Sept 2026, Ambalal Sarabhai Enterprises Ltd share price is ₹38.82. The stock opened at ₹38.82 and had closed at ₹38.66 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹23.12 and a high of ₹49.98. In terms of performance, Ambalal Sarabhai Enterprises Ltd share price has increased by 43.62% over the past six months and has increased by 21.39% over the last year.
AMBALALSA Stock Price Chart
Ambalal Sarabhai Enterprises Ltd Overview
Market cap₹297 Crs
Volume3,683
Prev. Close₹38.66
Year range₹23.12 - ₹49.98
ISININE432A01017
About AMBALALSA
Ambalal Sarabhai Enterprises is engaged in manufacturing Pharmaceuticals
Ambalal Sarabhai Enterprises Ltd Historical Performance
1 Month Return-14.27%
6 Month Return52.00%
3 Year Return5.98%
3 Month Return22.85%
1 Year Return26.74%
5 Year Return23.43%
Ambalal Sarabhai Enterprises Ltd Fundamentals
ROCE(TTM)14.69%
P/E Ratio (TTM)71.89
P/B Ratio5.00
Debt to Equity0.18
ROE18.48%
EPS (TTM)0.54
Dividend Yield0.00%
Book Value7.76
Profit Margin145.26%
Operating Margin-184.21%
Ambalal Sarabhai Enterprises Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 19.51 | 19.33 | 11.70 | 14.24 | 39.67 |
| EBITDA | 10.44 | 8.52 | 1.12 | 4.60 | 3.89 |
| Net Profit | 10.99 | 8.24 | 2.58 | 4.11 | 2.96 |
| EPS | 1.43 | 1.08 | 0.34 | 0.54 | 0.39 |
Ambalal Sarabhai Enterprises Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 38.14 |
| Resistance 1 (R1) | 39.59 |
| Pivot Point | 39.07 |
AMBALALSA Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Kartikeya V Sarabhai | Chairman |
| Mohal Kartikeya Sarabhai | Managing Director |
| Chaula Shastri | E D & Wholetime Directorector |
Ambalal Sarabhai Enterprises Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,846.40-1.20% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,352.00-0.62% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,935.00-0.70% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Ambalal Sarabhai Enterprises Ltd today is ₹38.82 on NSE and ₹38.82 on BSE.
- The 52-week high of Ambalal Sarabhai Enterprises Ltd is ₹49.98, while the 52-week low is ₹23.12.
- The current market capitalisation of Ambalal Sarabhai Enterprises Ltd is approximately ₹297 crore.
- The P/E (Price-to-Earnings) ratio of Ambalal Sarabhai Enterprises Ltd is 17.33. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Ambalal Sarabhai Enterprises Ltd is 1.30. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Ambalal Sarabhai Enterprises Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AMBALALSA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Ambalal Sarabhai Enterprises Ltd has delivered a return of approximately 5.98%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Ambalal Sarabhai Enterprises Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 31.36% promoters, 0.00% FIIs, 0.01% DIIs, and 58.90% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
